{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:27:42Z","timestamp":1792189662722,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["23-2679"],"award-info":[{"award-number":["23-2679"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","award":["ME2024-0027"],"award-info":[{"award-number":["ME2024-0027"]}],"id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lanepe.2025.101415","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:08:55Z","timestamp":1754406535000},"page":"101415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in Sweden"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-8000","authenticated-orcid":false,"given":"Juan","family":"Vaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1759","authenticated-orcid":false,"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-9528","authenticated-orcid":false,"given":"Per","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-7726","authenticated-orcid":false,"given":"Malin Sternby","family":"Eilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-5247","authenticated-orcid":false,"given":"Magnus","family":"Rizell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-1973","authenticated-orcid":false,"given":"Ulf","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lanepe.2025.101415_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.lanepe.2025.101415_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101415_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.lanepe.2025.101415_bib4","article-title":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101415_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2023.12.031","article-title":"Inequities in primary liver cancer in Europe: the state of play","volume":"80","author":"Kondili","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanepe.2025.101415_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101969","article-title":"Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database","volume":"59","author":"Liao","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101415_bib7","article-title":"Cholangiocarcinoma across England: temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation","volume":"6","author":"Tataru","year":"2024","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101415_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.33993","article-title":"Targeting population groups with heavier burden of hepatocellular carcinoma incidence: a nationwide descriptive epidemiological study in Sweden","volume":"151","author":"Vaz","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lanepe.2025.101415_bib9","article-title":"Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study","volume":"52","author":"Vaz","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101415_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","article-title":"Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register","volume":"40","author":"Everhov","year":"2025","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101415_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/0284186X.2021.1878550","article-title":"Small-area data on socioeconomic status and immigrant groups for evaluating equity of early cancer detection and care","volume":"60","author":"Stromberg","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.lanepe.2025.101415_bib12","series-title":"TNM classification of malignant tumours","author":"Brierley","year":"2016"},{"issue":"14","key":"10.1016\/j.lanepe.2025.101415_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2025.101415_bib14","series-title":"Revision of the european standard population \u2014 Report of Eurostat's task force","year":"2013"},{"issue":"82","key":"10.1016\/j.lanepe.2025.101415_bib15","first-page":"1","article-title":"Statistical methods in cancer research. Volume II--The design and analysis of cohort studies","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"issue":"5","key":"10.1016\/j.lanepe.2025.101415_bib16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101415_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/raon-2020-0008","article-title":"Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies","volume":"54","author":"Mihor","year":"2020","journal-title":"Radiol Oncol"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101415_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","article-title":"The exposome and liver disease - how environmental factors affect liver health","volume":"79","author":"Barouki","year":"2023","journal-title":"J Hepatol"},{"issue":"10319","key":"10.1016\/j.lanepe.2025.101415_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101415_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jep.12188","article-title":"Time and deprivation trends in incidence of primary liver cancer subtypes in England","volume":"20","author":"Konfortion","year":"2014","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101415_bib21","article-title":"Primary liver cancer in the UK: incidence, incidence-based mortality, and survival by subtype, sex, and nation","volume":"3","author":"Burton","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.lanepe.2025.101415_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102864","article-title":"Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom","volume":"76","author":"Scott","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101415_bib23","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1186\/s12889-025-22803-3","article-title":"Low levels of awareness and motivation towards cancer prevention amongst the general public in Sweden: a cross-sectional study focusing on the european code against cancer","volume":"25","author":"Hultstrand","year":"2025","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.lanepe.2025.101415_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10654-025-01226-9","article-title":"The healthcare system in Sweden","volume":"40","author":"Ludvigsson","year":"2025","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101415_bib25","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2468-2667(24)00002-1","article-title":"Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000\u201319: a systematic analysis of health disparities","volume":"9","author":"Nassereldine","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.lanepe.2025.101415_bib26","article-title":"New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"10","key":"10.1016\/j.lanepe.2025.101415_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/1750743X.2024.2347822","article-title":"Cost-effectiveness analysis of immune checkpoint inhibitors as first-line therapy in advanced biliary tract cancer","volume":"16","author":"Liu","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.lanepe.2025.101415_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102443","article-title":"Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data","volume":"69","author":"Hernando-Calvo","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101415_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:37:17Z","timestamp":1772919437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776225002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S2666776225002078"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101415","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in Sweden","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101496","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101415"}}